The site expansion bolsters Elanco’s monoclonal antibody (mAb) production; supports delivery of next-generation pipeline.
Elanco Ventures will support animal health and One Health innovation
The acquisition reflects broader industry movement toward integrated dairy production systems that combine feed, nutrition and animal health tools to improve long-term herd performance.
Much of the growth came from recent product launches that are gaining traction in key markets.